The global hemapheresis market is projected to showcase considerable growth during the forecast period. Hemapheresis is a medical procedure that involves removing whole blood from a donor’s body for separating and analyzing the individual components of the blood so that the desired blood component can be removed. This procedure is used for the collection of the blood components namely, plasma and platelets.The growth of the market is attributed to the increasing prevalence of chronic diseases that includes CHDs (Coronary Heart Diseases), CVDs (Cardiovascular Diseases), Cancer, neurological disorders, blood disorders among others. In addition, the growing demand for plasma in pharmaceutical and biotechnology companies is further expected to boost the growth of the global hemapheresis market.
To Request a Sample of our Report on Hemapheresis Market: https://www.omrglobal.com/request-sample/hemapheresis-market
There has been a significant increase in the number of patients with various blood-related diseases, neurological disorders and metabolic diseases across the globe. The blood cells, lymph nodes, and bone marrow are affected by various cancers including leukemia, and myelodysplastic syndromes (MDS). Hemapheresis has been widely adopted technology for reducing the number of white cells until other medications can control them. As per the Leukemia & Lymphoma Society (LLS) in 2018, approximately every 3 minutes, one person in the US is diagnosed with blood cancer. An estimated 1.3 million people in the US are either living with or are in remission from, leukemia, lymphoma or myeloma. With the rise in such disease, hemapheresistechnology has been widely adopted for the treatment of these diseases.
North America is projected to hold a considerable market share owing to the rising prevalence of chronic diseases in the region. According to WHO, the incidence and prevalence rate of heart attacks are highest in North America, which is responsible for 0.7 million fatalities each year. According to the Heart & Stroke Foundation in Canada alone, 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease.According to the report of Epilepsy Canada, in 2018, 0.6% of Canadian populations were having epilepsy. According to the National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer will be diagnosed in the US. The utility of hemapheresis to treat these diseases is expected to drive the growth of hemapheresis market in North America.
Current market trends covered in the market report
· Increasing prevalence of chronic diseases across the globe.
· Growing awareness related o blood safety across the globe.
· Asia-Pacific to exhibit a significant growth rate in the global hemapheresis market.
· Significant rise in the incidences of complex surgical procedures.
(Get 15% Discount on Buying this Report)
A full Report Hemapheresis Market is Available at: https://www.omrglobal.com/industry-reports/hemapheresis-market
Hemapheresis Market Segmentation
By Technology
· Centrifugation
· Membrane Separation
By Product
· Hemapheresis Devices
· Hemapheresis Disposables
By Application
· Hematology
· Neurology
· Renal Diseases
· Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
